Frontlight ResearchEarly access
CompletedNo phase
MLPR As A Diagnostic Marker For Acute Pulmonary Embolism
Key facts
- Who runs it
- Ain Shams University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 53 people enrolled
- Started
- 1 Jan 2024
- Ended
- 31 May 2025
- Type of study
- Observational, 2 groups
- Treatments tested
- Monocyte to Large Platelet Ratio (MLPR)
- Record updated
- 29 May 2026
Who can take part
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Only patients with the results of full blood count and white blood cell differentiation, measured before the treatment of suspected PE
- Patients underwent CT pulmonary angiography to confirm or exclude pulmonary embolism diagnosis
Who cannot take part
- Patient receiving any anticoagulant drug at a therapeutic dose
- Patient on immunosuppressive drugs , Oral contraceptive pills
- Patient with history of any myeloproliferative disorder, myelofibrosis, Glanzmann thrombasthenia, May-Hegglin anomaly, Bernard-Soulier syndrome, suspicion of disseminated intravascular coagulation
- Patients with acute coronary syndrome, pulmonary edema
- Patients with severe renal or hepatic disease
- Patients with Stroke
- Patients with malignancy
- Patient with blood transfusion in the last 2 months
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
A retrospective study to assess the utility of hematological marker (monocyte to large platelet ratio) to diagnose patients with pulmonary embolism
The 2 groups in the trial
- Pulmonary embolism
Group that is confirmed to have pulmonary embolism by positive CTPA finding filling defect.
Treatment: Monocyte to Large Platelet Ratio (MLPR)
- Non-Pulmonary embolism
Group that have pulmonary embolism diagnosis was excluded by negative CTPA finding.
Treatment: Monocyte to Large Platelet Ratio (MLPR)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Monocyte To Large Platelet Ratio As A Diagnostic Marker For Acute Pulmonary Embolism
- Record updated
- 29 May 2026